1. Home
  2. CNH vs CYTK Comparison

CNH vs CYTK Comparison

Compare CNH & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNH Industrial N.V.

CNH

CNH Industrial N.V.

HOLD

Current Price

$10.60

Market Cap

12.7B

Sector

Industrials

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$70.15

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNH
CYTK
Founded
1842
1997
Country
United Kingdom
United States
Employees
34197
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
10.4B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
CNH
CYTK
Price
$10.60
$70.15
Analyst Decision
Buy
Strong Buy
Analyst Count
11
19
Target Price
$13.00
$89.26
AVG Volume (30 Days)
10.3M
1.7M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
0.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
N/A
$7.37
Revenue Next Year
$8.21
$310.19
P/E Ratio
$31.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.00
$31.99
52 Week High
$13.87
$80.20

Technical Indicators

Market Signals
Indicator
CNH
CYTK
Relative Strength Index (RSI) 49.39 46.76
Support Level $9.85 $59.07
Resistance Level $11.13 $70.69
Average True Range (ATR) 0.40 2.86
MACD -0.00 -0.94
Stochastic Oscillator 53.47 30.07

Price Performance

Historical Comparison
CNH
CYTK

About CNH CNH Industrial N.V.

CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agricultural sales are 40% in North America, 32% in Europe, the Middle East, and Africa, 18% in South America, and 10% in Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers and wholesale financing to dealers to maintain inventory, thereby supporting sales.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: